Venus Remedies partners with West Pharmaceutical Services to launch Cloti-Xa in India

Venus Remedies has inked partnership with West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, for its new introduction in the fast-growing low molecular weight heparin market with brand Cloti-Xa, which has adopted NovaGuard SA Pro safety system, a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes.

Cloti-Xa which contains enoxaparin sodium is being introduced with added advantage of NovaGuard SA Pro safety system which is a revolutionary product that helps and protects healthcare workers and patients from accidental needlestick injuries. This innovative product has been commented to deliver a compelling total cost of ownership in that it prevents pre-activation, offers a lower syringe snap-in force and a lower activation force for end-user comfort, and mitigates the practice of recapping which helps to provide tamper evidence to customers.

Venus Remedies is one of the handful player in pharmaceutical sector to launch world global injectable manufacturers. It has world-class manufacturing facilities in Panchkula and Baddi (in India) and Werne (in Germany) and research and development center in Venus Medicine Research Centre (in India).